http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1338737-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95c51305b25e433ac11f598e22d58a14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1989-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e2132084791df330a00cd8f4359ae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d5d795aa8eb5652a2fd63aae4bdd1c
publicationDate 1996-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1338737-C
titleOfInvention Porphyrins and cancer treatment
abstract This invention provides novel compounds for therapy of tumours susceptible to necrosis when an appropriate compound is administered followed by illumination with light of a wavelength absorbed by the compound, the compounds being dihydro porphyrins of the formula, or the corresponding tetra-hydro porphyrins: IV where n = 1 to 3 and each substituent R, the same or different and at the same or different position in its respective substituent phenyl ring, is an hydroxy group.
priorityDate 1988-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424547671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2735129
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152767075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495609
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450183611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422075064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5493302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415750929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66788048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148548075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152779678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411297520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449323691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8371

Total number of triples: 53.